103 related articles for article (PubMed ID: 4755955)
1. [Pathogenesis and treatment of vitiligo].
Borisenko KK
Vestn Dermatol Venerol; 1973 May; 47(5):11-6. PubMed ID: 4755955
[No Abstract] [Full Text] [Related]
2. [The pathogenesis of vitiligo].
Gudzenko ZhP; Kartysh GA; Zaĭchenko KI; Klenus IuN; Korotkaia EV
Vrach Delo; 1989 Jun; (6):95-8. PubMed ID: 2781779
[TBL] [Abstract][Full Text] [Related]
3. [Problems of pathogenesis and treatment of vitiligo].
Vedrova IN; Kriazheva SS; Udzhukhu VIu; Korotkiĭ NG
Vestn Dermatol Venerol; 1987; (3):33-6. PubMed ID: 3037816
[No Abstract] [Full Text] [Related]
4. [Catamnesis of vitiligo patients].
Lonshakov IuI
Vestn Dermatol Venerol; 1985 Jan; (1):48-50. PubMed ID: 3976295
[No Abstract] [Full Text] [Related]
5. [Pathogenesis of dyschromia (trace elements in vitiligo)].
Lonshakov IuI; Syrkin AM; Timakin NP
Vestn Dermatol Venerol; 1973 Apr; 47(4):25-9. PubMed ID: 4709908
[No Abstract] [Full Text] [Related]
6. [Adrenal cortex function in patients with vitiligo].
Borisenko KK
Sov Med; 1971 Sep; 34(9):107-10. PubMed ID: 5121273
[No Abstract] [Full Text] [Related]
7. [Vitiligo].
Belova LV
Med Sestra; 1985 Aug; 44(8):45-7. PubMed ID: 3851150
[No Abstract] [Full Text] [Related]
8. [Clinical manifestations of thyrotoxicosis].
Conde Yagüe R; Ortiz Ortiz M
Rev Clin Esp; 1981 Jan; 160(1):23-9. PubMed ID: 7209047
[No Abstract] [Full Text] [Related]
9. [Dopegit in the combined treatment of vitiligo patients].
Mirakhmedov UM; Rakhmatov BR; Rakhmatov AB; Raimdzhanova MR; Kamzolova KP
Vestn Dermatol Venerol; 1985 Jun; (6):56-8. PubMed ID: 4036307
[No Abstract] [Full Text] [Related]
10. [Vitiligo].
Njoo MD; Westerhof W
Ned Tijdschr Geneeskd; 1997 Apr; 141(16):759-64. PubMed ID: 9213796
[TBL] [Abstract][Full Text] [Related]
11. [Oral treatment of vitiligo with 8-methoxypsoralen and triamcinolone].
Petzoldt D; Reich AL
Hautarzt; 1974 Apr; 25(4):191-4. PubMed ID: 4849308
[No Abstract] [Full Text] [Related]
12. [Carbohydrate metabolism disorders in patients with vitiligo].
Chojnacki J; Kaszuba A; Gajewska B; Dubiecki W
Przegl Dermatol; 1976; 63(4):455-9. PubMed ID: 968076
[No Abstract] [Full Text] [Related]
13. Topical immunomodulators are effective for treatment of vitiligo.
Choi CW; Chang SE; Bak H; Choi JH; Park HS; Huh CH; Kim CW; Kim SE; Mun SK; Kim BJ; Kim MN
J Dermatol; 2008 Aug; 35(8):503-7. PubMed ID: 18789070
[TBL] [Abstract][Full Text] [Related]
14. High-dose prednisolone and psoralen ultraviolet A combination therapy in 36 patients with vitiligo.
Lee Y; Seo YJ; Lee JH; Park JK
Clin Exp Dermatol; 2007 Sep; 32(5):499-501. PubMed ID: 17608760
[TBL] [Abstract][Full Text] [Related]
15. Etiopathogenesis of vitiligo in the light of our studies.
Chorazak T; Rzempoluch E
Pol Med J; 1968; 7(2):494-500. PubMed ID: 5658063
[No Abstract] [Full Text] [Related]
16. [Vitiligo in patients with porphyria].
Guseinov MM
Vestn Dermatol Venerol; 1973 Jun; 47(6):11-4. PubMed ID: 4764148
[No Abstract] [Full Text] [Related]
17. [Treatment of vitiligo in children with copper sulfate].
Bagaeva MI
Vestn Dermatol Venerol; 1979 Mar; (3):48-50. PubMed ID: 371236
[No Abstract] [Full Text] [Related]
18. Role of tacrolimus (FK506) 0.1% ointment WW in vitiligo in children and imperatives of combine therapy with Trioxsalen and Silymarin suspension in progressive vitiligo.
Sehgal VN
J Eur Acad Dermatol Venereol; 2009 Oct; 23(10):1218-9. PubMed ID: 19192018
[No Abstract] [Full Text] [Related]
19. [Role of trace elements in the pathogenesis of vitiligo].
Vaisov ASh; Kadyrov EA; Rakhimova MA; Muratkhodzhaeva ShN
Vestn Dermatol Venerol; 1985 Sep; (9):38-40. PubMed ID: 4090707
[No Abstract] [Full Text] [Related]
20. Vitiligo.
Punshi SK
Q Med Rev; 1979 Oct; 30(4):1-46. PubMed ID: 396546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
